kaempferide
CAS No. 491-54-3
kaempferide ( Kaempferide )
Catalog No. M18646 CAS No. 491-54-3
Kaempferide triglycoside inhibits the proliferation of native and estrogen receptor beta overexpressing colon cancer cells through a mechanism not mediated by ligand binding dependent estrogen receptor activation.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 261 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Namekaempferide
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaempferide triglycoside inhibits the proliferation of native and estrogen receptor beta overexpressing colon cancer cells through a mechanism not mediated by ligand binding dependent estrogen receptor activation.
-
DescriptionKaempferide triglycoside inhibits the proliferation of native and estrogen receptor beta overexpressing colon cancer cells through a mechanism not mediated by ligand binding dependent estrogen receptor activation.
-
SynonymsKaempferide
-
PathwayOthers
-
TargetOther Targets
-
RecptorER
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number491-54-3
-
Formula Weight300.27
-
Molecular FormulaC16H12O6
-
Purity98%
-
SolubilityDMSO : 20 mg/mL 66.61 mM;
-
SMILESCOc1ccc(cc1)c1c(c(=O)c2c(cc(cc2o1)O)O)O
-
Chemical Name3,5,7-trihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Song P,et al. [Comparison of effects of kaempferide and anhydroicaritin on biomineralization of cultured osteoblasts]. Yao Xue Xue Bao. 2012 Jul;47(7):890-6.
molnova catalog
related products
-
Raffinose(b)
Raffinose is a natural compound.
-
SEP-0371845
SEP-0371845 is a biochemical.
-
β-Casomorphin (1-5),...
β-Casomorphin Fragment 1-5 (BCM5), an opioid receptor agonist, is a member of the β-casomorphin peptide family derived from β-casein. β-casomorphins are used to study their differential effects on processes such as hyperglycemia, oxidative stress, opioid signalling and immunosuppression.